Silver Book Fact

Visual loss from subfoveal choroidal neovascularization, a characteristic of wet age-related macular degeneration (AMD), was found to have a profound impact on how patients felt about their health-related quality of life–rating it as low or lower than patients with renal failure and AIDS.

Bass, Eric B., Marta J. Marsh, Carol M. Mangione, Neil M. Bressler, Ashley L. Childs, Li Ming Dong, Barbara S. Hawkins, Harris A. Jaffee, and Paiva H. Miskala. Patients’ Perceptions of the Value of Current Vision: Assessment of preference values among patients with subfoveal choroidal neovascularization– The Submacular Surgery Trials Vision Preference Value Scale. Arch Opthalmol. 2004; 122(12): 1856-67. http://archopht.ama-assn.org/cgi/content/abstract/122/12/1856

Reference

Title
Patients’ Perceptions of the Value of Current Vision: Assessment of preference values among patients with subfoveal choroidal neovascularization– The Submacular Surgery Trials Vision Preference Value Scale
Publication
Arch Opthalmol
Publication Date
2004
Authors
Bass, Eric B., Marta J. Marsh, Carol M. Mangione, Neil M. Bressler, Ashley L. Childs, Li Ming Dong, Barbara S. Hawkins, Harris A. Jaffee, and Paiva H. Miskala
Volume & Issue
Volume 122, Issue 12
Pages
1856-67
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Related Facts

  • For beneficiaries with wet age-related macular degeneration (AMD), annual Medicare part B payments for vision care increased from $1,504 per beneficiary in 1994 to $3,263 in 2006–due in large part…  
  • Of the study participants in the Los Angeles Latino Eye Study (LALES) who had open-angle glaucoma, 75% were previously undiagnosed.  
  • Adults 60 years and older are 6 times more likely to develop glaucoma.  
  • The total annual loss for the 3.7 million people in the U.S. who are visually impaired or blind is estimated at more than 209,000 quality-adjusted life-years.  
  • Individuals who are visually impaired are less likely to be employed–44% are employed compared to 85% of adults with normal vision.